help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hall, J. E.
Right arrow Articles by Crowley, W. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hall, J. E.
Right arrow Articles by Crowley, W. F., Jr

Journal of Clinical Endocrinology & Metabolism, Vol 70, 328-335, Copyright © 1990 by Endocrine Society


ARTICLES

Differential regulation of luteinizing hormone, follicle-stimulating hormone, and free alpha-subunit secretion from the gonadotrope by gonadotropin-releasing hormone (GnRH): evidence from the use of two GnRH antagonists

JE Hall, RW Whitcomb, JE Rivier, WW Vale and WF Crowley Jr
Reproductive Endocrine Unit, Massachusetts General Hospital, Boston 02114.

To examine the differential regulation of glycoprotein hormone secretion from the gonadotrope by GnRH, the Nal-Glu GnRH antagonist was administered to euthyroid women in the early follicular phase (days 1- 5) of the menstrual cycle, and the results compared to previous studies with the Nal-Arg GnRH antagonist. After a 4-h period of baseline sampling at a frequency of every 10 min, a single sc dose of the GnRH antagonist was administered to each subject. Frequent sampling continued for 8 h, followed by hourly sampling for a further 16 h. LH, FSH, and free alpha-subunit were measured serially in assays with high specificity. There was a 90% concordance of LH and free alpha-subunit pulses during the baseline sampling period. Pulsatile secretion of LH and free alpha-subunit was immediately abolished at the highest dose of the Nal-Glu antagonist for at least 8 h. The maximum percent suppression of LH after administration of the Nal-Glu GnRH antagonist was 70 +/- 4%, 80 +/- 4%, and 83 +/- 1% at doses of 15, 50, and 150 micrograms/kg, respectively, compared to 51 +/- 10%, 70 +/- 5%, and 69 +/- 5% at doses of 50, 150, and 500 micrograms/kg Nal-Arg antagonist. Decreases in FSH were 28 +/- 2%, 32 +/- 7%, and 39 +/- 2%, with increasing doses of the Nal-Glu antagonist compared with 25 +/- 6%, 17 +/- 6%, and 28 +/- 4% reductions at increasing doses of the Nal-Arg antagonist. Free alpha-subunit decreased 22 +/- 4%, 23 +/- 4%, and 28 +/- 3% at increasing doses of the Nal-Glu antagonist and 12 +/- 4%, 27 +/- 4%, and 30 +/- 7% with increasing doses of the Nal-Arg antagonist. For the Nal-Glu antagonist, suppression of LH was greater than that of FSH and free alpha-subunit at all doses (P less than 0.001), while FSH suppression was greater than that of free alpha-subunit at the highest dose only (P less than 0.05). For the Nal-Arg antagonist, LH suppression was greater than that of FSH or free alpha-subunit at all doses (P greater than 0.01), and FSH suppression exceeded that of free alpha-subunit at the 50 micrograms/kg dose. Suppression of LH was greater with the Nal-Glu antagonist than with the Nal-Arg antagonist at doses of 50 and 150 micrograms/kg (P less than 0.05), and FSH suppression was greater with the Nal-Glu antagonist at 150 micrograms/kg (P less than 0.01), while the degrees of maximum suppression were similar for the two different GnRH antagonists for free alpha-subunit.(ABSTRACT TRUNCATED AT 400 WORDS)


This article has been cited by other articles:


Home page
J Biol RhythmsHome page
H. B. Lavoie, E. E. Marsh, and J. E. Hall
Absence of Apparent Circadian Rhythms of Gonadotropins and Free {alpha}-Subunit in Postmenopausal Women: Evidence for Distinct Regulation Relative to Other Hormonal Rhythms
J Biol Rhythms, February 1, 2006; 21(1): 58 - 67.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Gill, J. L. Sharpless, K. Rado, and J. E. Hall
Evidence That GnRH Decreases with Gonadal Steroid Feedback but Increases with Age in Postmenopausal Women
J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2290 - 2296.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Couzinet, J. Pantel, P. Chanson, J. Young, S. Brailly, I. T. Huhtaniemi, J.-M. Bidart, and G. Schaison
Measurement of Plasma Free Luteinizing Hormone {beta}-Subunit in Women
J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2293 - 2298.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
J. E. Hall, H. B. Lavoie, E. E. Marsh, and K. A. Martin
Decrease in Gonadotropin-Releasing Hormone (GnRH) Pulse Frequency with Aging in Postmenopausal Women
J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1794 - 1800.
[Abstract] [Full Text]


Home page
Hum ReprodHome page
J. Oberye, B. Mannaerts, J. Huisman, and C. Timmer
Local tolerance, pharmacokinetics, and dynamics of ganirelix (Orgalutran(R)) administration by Medi-Jector(R) compared to conventional needle injections
Hum. Reprod., February 1, 2000; 15(2): 245 - 249.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. K. Welt, J. M. Adams, P. M. Sluss, and J. E. Hall
Inhibin A and Inhibin B Responses to Gonadotropin Withdrawal Depends on Stage of Follicle Development
J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2163 - 2169.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
F. J. Hayes, D. J. McNicholl, D. Schoenfeld, E. E. Marsh, and J. E. Hall
Free {alpha}-Subunit Is Superior to Luteinizing Hormone as a Marker of Gonadotropin-Releasing Hormone Despite Desensitization at Fast Pulse Frequencies
J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 1028 - 1036.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
S. B. Seminara, F. J. Hayes, and W. F. Crowley Jr.
Gonadotropin-Releasing Hormone Deficiency in the Human (Idiopathic Hypogonadotropic Hypogonadism and Kallmann's Syndrome): Pathophysiological and Genetic Considerations
Endocr. Rev., October 1, 1998; 19(5): 521 - 539.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
F. J. Hayes, A. E. Taylor, K. A. Martin, and J. E. Hall
Use of a Gonadotropin-Releasing Hormone Antagonist as a Physiologic Probe in Polycystic Ovary Syndrome: Assessment of Neuroendocrine and Androgen Dynamics
J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2343 - 2349.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
H. B. Lavoie, K. A. Martin, A. E. Taylor, W. F. Crowley, and J. E. Hall
Exaggerated Free {alpha}-Subunit Levels during Pulsatile Gonadotropin-Releasing Hormone Replacement in Women with Idiopathic Hypogonadotropic Hypogonadism
J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 241 - 247.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Albertsson-Wikland, S. Rosberg, B. Lannering, L. Dunkel, G. Selstam, and E. Norjavaara
Twenty-Four-Hour Profiles of Luteinizing Hormone, Follicle-Stimulating Hormone, Testosterone, and Estradiol Levels: A Semilongitudinal Study throughout Puberty in Healthy Boys
J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 541 - 549.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
V. Padmanabhan, K. McFadden, D. T. Mauger, F. J. Karsch, and A. R. Midgley Jr.
Neuroendocrine Control of Follicle-Stimulating Hormone (FSH) Secretion. I. Direct Evidence for Separate Episodic and Basal Components of FSH Secretion
Endocrinology, January 1, 1997; 138(1): 424 - 432.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society